Alibaba Group Holding Ltd (NYSE:BABA) is down 2% in pre-market down to $79.30 after the Chinese e-commerce company disclosed an SEC investigation last night in an annual filing report, indicating that the company is the subject of a US accounting inquiry. Alibaba ensures that it is cooperating with the SEC by providing the necessary documents, and that this should not be misconstrued into a violation. Alibaba has cautioned that this ordeal may harm its reputation, but it is an ongoing investigation and they cannot predict when it will be closed.
According to TipRanks, all 13 analysts who have rated the company in the last 3 months are bullish with an average 12-month price target of $100.33, marking a 23% potential upside from where shares last closed.
Sarepta Therapeutics Inc (NASDAQ:SRPT) is up 22% in pre-market trading after the company announced that the FDA will not complete a review of eteplirsen, its DMD drug, by its May 26 PDUFA deadline. The delay is raising hopes of both investors and patients that the drug will be approved. Two other biotech companies, PTC Therapeutics and BioMarin Pharmaceuticals, had DMD drugs rejected this year, putting additional pressure on the approval of etepliresn as DMD patients are desperate for a treatment, which kills most patients by age 25.
According to TipRanks’ statistics, out of the 13 analysts who have rated the company in the past 3 months, 4 gave a Buy rating, 4 gave a Sell rating, and 5 remain on the sidelines. The average 12-month price target for the stock is $13.20, marking a 28% downside from where shares last closed.
Hewlett Packard Enterprise Co (NYSE:HPE) is up 12% in pre-market trading after reporting better than expected Q2:16 earnings yesterday after market close. The company reported revenues of $12.7 billion, topping consensus estimates of $12.4 billion for the quarter, and in-line earnings of $0.42 per share. The company experienced success with its enterprise group, including servers, storage, and other related operations.
Most notably, the company announced it is spinning off and merging its enterprise services business with Computer sciences (CSC) for $8.5 billion, creating a major player in IT services. The merger will not only create higher margins and faster growth, but will also result in stronger FCF. The deal is expected to close by Q1:17 and result in cost synergies of $1 billion after the first year. CEO of HPE Meg Whitman stated, “We believe this industry will consolidate.” She continued, “It’s better to be on the front end of a consolidation play than on the back end of a consolidation play.”
Following this announcement, Needham analyst Richard Kugele upgraded the company rom hold to Buy and set a price target of $22. He states, “In our view, one thing HP in the Meg Whitman era has done successfully is find opportune times to divest assets…. the business is finally generating improving operating margins enough to find a buyer (which would not have been possible at the time of the split in 2014)…”
According to TipRanks, out of the 12 analysts who have rated the company in the past 3 months, 8 gave a Buy rating and 4 remain neutral. The average 12-month price target for the stock is $19.72, marking a 21% upside from where shares last closed.
Yahoo! Inc. (NASDAQ:YHOO) is down more than 2% in pre-market trading down to $36.75 following news that Alibaba is the subject of a US accounting inquiry. Yahoo has a significant stake in Alibaba, last reported to be valued at $30 billion. While this new probe does not indicate wrongdoing, Alibaba warned that just the nature of the inquiry may harm its reputation. Alibaba has provided all the requested documentation but is unable to provide a timeline of when the investigation will be concluded.
According to TipRanks, 12 analysts are bullish on Yahoo, 12 are neutral, and 1 is bearish. The average 12-month price target between these 25 analysts is $42.07, marking a 12% potential upside from where shares last closed.